Gregory Thaxton
Analyst · Gabelli Research
Thank you, Mike, and good morning to everyone. First quarter sales decreased 10% compared to the prior year's first quarter. This change in sales included a decrease of 9% organic volume, growth related to the first year effect of acquisitions of 1% and a decrease of 2% related to the unfavorable effects of currency translation as compared to the prior year's first quarter. First quarter's acquisitive growth includes the fiscal 2018 acquisition of Clada Medical Devices and two months of the fiscal 2018 acquisition of Sonoscan. As Mike noted, our first quarter performance was largely in line with our expectations as we were up against an exceptional prior year first quarter. Within the Adhesive Dispensing Systems segment, sales decreased approximately 4% compared to the prior year's first quarter, inclusive of a decrease in organic volume of approximately 2% and a decrease of approximately 3% related to the unfavorable effects of currency translation as compared to the prior year. We did deliver organic growth in most product lines. However, this segment's performance was offset by nonwoven product line sales, where system sales tend to be larger dollar and order patterns can be sporadic depending upon new OEM lines or customer line upgrades. As noted, we were up against very challenging comparisons within the Advanced Technology Systems segment, where prior year first quarter organic sales volume increased 50%. In the current year, first quarter sales decreased approximately 14% compared to the prior year's first quarter, inclusive of a decrease in organic volume of approximately 15%, an increase of approximately 2% related to the first year effect of acquisitions, and a decrease of approximately 1% related to the unfavorable effects of currency translation as compared to the prior year. Double-digit growth within the fluid management product lines and solid growth within test and inspection product lines was offset largely by the difficult comparison for the dispensing product lines associated with electronic end markets. Industrial Coating Systems segment sales decreased approximately 10% compared to the prior year's first quarter, inclusive of a decrease in organic volume of approximately 9% and a decrease of approximately 2% related to the unfavorable effects of currency translation as compared to the prior year. Softer demand for cold material product lines associated with automotive end markets had the largest impact as compared to the prior year. And like other larger-dollar system sales, demand can be lumpy for product lines within this segment. Moving down the income statement, gross margin for the total company was 54% in the quarter. Operating profit was $84 million, with reported operating margin of 17%. Regarding the adhesive facility consolidation initiative that we have talked about in previous quarters, we incurred approximately $1 million of duplicate costs during the quarter. We do not expect duplicate costs to be material for the remainder of the fiscal year. In addition, we incurred restructuring charges of approximately $1.5 million during the quarter, with most of this cost related to the adhesive facility consolidation initiative. As Mike noted earlier, operating margin for each of the segments was negatively impacted by lower sales volume in the quarter. We expect this year's performance to play out in line with historical seasonal patterns, where incremental sales generate significant margin leverage. On a total company basis, net income for the quarter was $49 million, and GAAP diluted earnings per share were $0.83, inclusive of approximately $0.09 per share of charges related to onetime items. These onetime items include nonrecurring restructuring charges of $0.02 per share. Additionally, a net discrete tax charge of approximately $4 million or $0.07 per diluted share was recognized in the quarter, primarily related to the U.S. federal income tax reform legislation. We delivered first quarter EBITDA of $108 million or 22% of sales, inclusive of the $1.5 million of restructuring charges and approximately $1 million of duplicate costs associated with the adhesive facility consolidation. Free cash flow before dividends during the quarter was $43 million or 89% of net income. This cash conversion ratio is typical for our first quarter. Our press release includes financial exhibits reconciling net income to free cash flow before dividends and adjusted free cash flow before dividends as well as EBITDA and adjusted EBITDA. From a balance sheet perspective, net debt to EBITDA was approximately 2.3x trailing 12 months' EBITDA at the end of the first quarter, where we maintained adequate capacity for strategic priorities. I'll now turn the call back over to Mike for a few closing comments.